COMPANY
Apyx Medical
Timeline
- Trial start Not phased (device or behavioral study): Within-Subject Comparison of Adipose Tissue Viability Following Liposuction source ↗
- Raise Follow-on offering: $10M (total, as published), announced Nov 18, 2025. Source: SEC filing. source ↗
- Raise Follow-on offering — Registered direct: $7M (total, as published), announced Nov 8, 2024. Source: SEC filing. source ↗
- Trial start Not phased (device or behavioral study): Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery source ↗
- Trial start Not phased (device or behavioral study): Measuring Renuvion Soft Tissue Contraction Using Ultrasound source ↗
- Trial start Not phased (device or behavioral study): Evaluation of the Use of the Renuvion APR System in the Labia source ↗
- Trial start Not phased (device or behavioral study): A Post-Market Study in Greece of a Minimally Invasive Breast Lift Procedure Utilizing the Renuvion APR System source ↗
- Trial start Not phased (device or behavioral study): Post-Market Lower Eyelid Treatment With Renuvion in Greece source ↗
- Trial start Not phased (device or behavioral study): Renuvion APR System When Used as an Adjunct Procedure In Gynecomastia Surgery source ↗
- Trial start Not phased (device or behavioral study): Renuvion Dermal System for Dermal Resurfacing source ↗
- Trial start Not phased (device or behavioral study): Renuvion APR Device to Improve the Appearance of Lax Tissue in the Neck and Submental Region source ↗
- Trial start Not phased (device or behavioral study): The Use of J-Plasma® for Dermal Resurfacing source ↗
- Trial start Not phased (device or behavioral study): Cold Plasma for the Reduction of Lymphoceles Following PLND source ↗
Upcoming milestones
- Dec 31, 2026 (ESTIMATED) · Not phased · Within-Subject Comparison of Adipose Tissue Viability Following Liposuction · NCT07820397
Funding
Clinical trials (lead sponsor) 11
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07820397 | Within-Subject Comparison of Adipose Tissue Viability Following Liposuction | Not phased (device or behavioral study) | Recruiting | Aug 6, 2026 | Dec 31, 2026 (estimated) |
| NCT06243744 | Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery | Not phased (device or behavioral study) | Completed | Nov 30, 2023 | Jul 10, 2025 (actual) |
| NCT05323630 | Evaluation of the Use of the Renuvion APR System in the Labia | Not phased (device or behavioral study) | Completed | Apr 19, 2023 | Apr 23, 2024 (actual) |
| NCT05665335 | A Post-Market Study in Greece of a Minimally Invasive Breast Lift Procedure Utilizing the Renuvion APR System | Not phased (device or behavioral study) | Completed | Nov 28, 2022 | Apr 26, 2024 (actual) |
| NCT05605691 | Post-Market Lower Eyelid Treatment With Renuvion in Greece | Not phased (device or behavioral study) | Completed | Oct 11, 2022 | Mar 5, 2024 (actual) |
| NCT05968495 | Measuring Renuvion Soft Tissue Contraction Using Ultrasound | Not phased (device or behavioral study) | Completed | Jun 1, 2023 | Sep 30, 2024 (actual) |
| NCT05093049 | Renuvion APR System When Used as an Adjunct Procedure In Gynecomastia Surgery | Not phased (device or behavioral study) | Completed | Oct 22, 2021 | Aug 17, 2022 (actual) |
| NCT03286283 | The Use of J-Plasma® for Dermal Resurfacing | Not phased (device or behavioral study) | Completed | Jan 22, 2018 | Aug 20, 2018 (actual) |
| NCT04146467 | Renuvion APR Device to Improve the Appearance of Lax Tissue in the Neck and Submental Region | Not phased (device or behavioral study) | Completed | Nov 26, 2019 | Feb 28, 2022 (actual) |
| NCT04185909 | Renuvion Dermal System for Dermal Resurfacing | Not phased (device or behavioral study) | Completed | Dec 30, 2019 | Mar 23, 2021 (actual) |
| NCT02658851 | Cold Plasma for the Reduction of Lymphoceles Following PLND | Not phased (device or behavioral study) | Completed | 2016-06 | Jun 27, 2017 (actual) |